David Dolby is an active technology investor and philanthropist based in San Francisco. Under Ray Dolby’s mentorship, David has developed a strong skill set to identify tough problems worth solving and ways to change the world through technology and media.
David oversees a portfolio of family investments across a wide range of asset classes that include private equity, venture capital and real estate. He directly manages a portfolio of over 20 venture investments ranging across Internet technology, aerospace, digital marketing and retail platforms, Alzheimer’s drug discovery, cognitive health, medical diagnostics, security and cryptography, 3D printing, virtual reality media platforms, independent film impact investments, and consumer products.
David serves as a director of Dolby Laboratories and is a member of the technology strategy committee focused on long-term growth opportunities. David is also a director of Cogstate Limited, where he serves on the audit, nominating and governance, and compensation committees. David is also the CFO of the Ray and Dagmar Dolby Family Fund, supporting a variety of not-for-profit initiatives in academic and research institutions, and other social impact sectors. David serves as a board member of Tipping Point focused on addressing root causes of poverty in the Bay Area.
David has a BSE in Civil Engineering from Duke University and an MBA from the Stanford Graduate School of Business. David has studied overseas in Salamanca, Spain; Oxford, England; and Erlangen, Germany. David completed a year-long program at the Philanthropy Workshop West with a focus on impact investing. David has been a guest speaker at the Milken Global Conference and various impact investment and philanthropy conferences. David participates regularly in public company directors’ programs, including Stanford University’s Rock Center for Corporate Governance and Harvard Business School.
David is committed to honoring Ray Dolby’s values, his belief in supporting highly innovative cultures, and in furthering the impact of his outstanding legacy.
Pascal joined Dolby Family Ventures, L.P. as a Managing Director in 2014 after advising the Dolby family on its direct technology investment portfolio since 2012. Since 1996, Pascal has been the Managing Partner of Levensohn Venture Partners LLC (LVP) and the CEO of Generation Strategic Advisors LLC (GSA) and its predecessor entities. While he continues to serve in both of these positions, Pascal has transitioned his new technology venture capital investing activities to the Dolby family organization.
GSA advises institutional investors and sophisticated family offices on due diligence, investment structure, and corporate governance, principally related to direct venture capital and private equity investments. LVP invested over $200 million in early and development stage emerging companies, emphasizing semiconductor, security, digital media, and enterprise software sectors across three funds.
Pascal is a former director of the National Venture Capital Association (2007-2011). He is a faculty member of the Kauffman Fellows Program Center for Venture Education (2006-present) where he teaches best practices for VC-backed company board members. In 2016 Pascal joined the Advisory Board to the rector of the University of Applied Sciences Salzburg, Austria, where he is also a guest lecturer on Entrepreneurship (Fachhochschule Salzburg ). Pascal is a life member of the Council on Foreign Relations. In November 2016 he was elected a Trustee of the American Academy in Berlin.
Pascal has served as board chairman, audit committee chairman, compensation committee chairman, and board secretary for venture-backed companies since 1996 and first served as a public company director since 1993. Pascal is the Chairman of the board of ShotSpotter, Inc., a director of Mixed Dimensions, Inc., and a director of Cure Network Dolby Acceleration Partners LLC (joint venture with The Gladstone institutes).
Pascal has lectured on board governance topics at top universities in the U.S. (Harvard Law School, Stanford School of Engineering, Stanford Rock Center Venture Capital Directors College), China, and Singapore.
Pascal holds an AB in Government, cum laude, from Harvard University. He is a former co-chairman of the Socrates Society Forum of the Aspen Institute (2007-2009), and a former Chairman of the San Francisco Jewish Community Federation’s Business Leadership Council (2007-2008).
Andrew is a Principal at Dolby Family Ventures, L.P. and joined in 2014 after earning his MBA at the Haas School of Business at UC-Berkeley, where he graduated with honors. While at Haas, Andrew was the recipient of the inaugural Investment Management Fellowship and the CFA Merit Award and served as a Consortium Fellow. He is also a Kauffman Fellow, Class 22.
Prior to business school, Andrew worked for five years at various Investment Banks in New York including RBS, Barclays Capital, and Merrill Lynch. He covered the Technology, Telecom & Media sector, focused on the capital markets. His responsibilities included advising US and European companies on corporate financing strategies within debt capital markets, rates/FX risk management, and various alternative funding vehicles. Andrew previously worked at two hedge funds and began his career in the Valuation Advisory Practice of Ernst & Young.
Andrew earned a BS degree from the University of Virginia’s McIntire School of Commerce in 2006, where he had a double-concentration in Finance and Accounting.
Deanna Belsky, PhD
Deanna joined Dolby Family Ventures in 2018 as an Associate. She completed postdoctoral work at Stanford University, studying general molecular mechanisms in neurodegeneration, and she earned her PhD from Rockefeller University, studying ALS in Marc Tessier-Lavigne’s laboratory. Deanna has an accumulated 10 years of laboratory experience and is a recipient of the National Science Foundation Fellowship, Women in Science Grant, and Neuroscience Fellowship at Rockefeller University.
Prior to joining the Dolby Family Ventures team, Deanna worked at a boutique biotech hedge fund and a life sciences consulting firm. Her responsibilities included scientific diligence of company technology and therapeutics, competitive landscape analysis, evaluating clinical trials, and forecast modeling.
Deanna earned a BS in Biochemistry and a BA in Asian Studies at Indiana University of Pennsylvania in 2011, graduating summa cum laude. She also spent a summer at Sichuan University studying Mandarin.